- Previous Close
133.00 - Open
146.00 - Bid 146.00 x --
- Ask 146.00 x --
- Day's Range
143.00 - 146.00 - 52 Week Range
112.50 - 165.50 - Volume
1,288,334 - Avg. Volume
1,513,687 - Market Cap (intraday)
16.162B - Beta (5Y Monthly) 0.62
- PE Ratio (TTM)
19.34 - EPS (TTM)
7.55 - Earnings Date May 9, 2025
- Forward Dividend & Yield 7.00 (4.62%)
- Ex-Dividend Date Jul 23, 2024
- 1y Target Est
173.00
TCI Co., Ltd., an original design manufacturer company, engages in the manufacturing, wholesale, and retail of health foods and cosmetics products in Taiwan, Mainland China, the United States, and internationally. The company offers liquid and solid supplements; immunity products; functional probiotics; basic nutrition; detox slimming; body health; sports nutrition supplements product; laundry detergents; hand sanitizers; and functional snacks, which includes, jelly, bars, chocolates, and gummies. It also provides skin care products, such as facial, body sheet, eye, and lip masks; essences; functional sprays; creams; and gels, as well as turnkey services. In addition, the company involved in wholesale of chemical production; research and development of biotechnology and genetics; and selling medical machinery. TCI Co., Ltd. was incorporated in 1980 and is headquartered in Taipei, Taiwan.
www.tci-bio.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 8436.TWO
View MorePerformance Overview: 8436.TWO
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8436.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8436.TWO
View MoreValuation Measures
Market Cap
14.72B
Enterprise Value
10.88B
Trailing P/E
17.62
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.07
Price/Book (mrq)
1.82
Enterprise Value/Revenue
1.50
Enterprise Value/EBITDA
6.11
Financial Highlights
Profitability and Income Statement
Profit Margin
11.76%
Return on Assets (ttm)
4.62%
Return on Equity (ttm)
10.06%
Revenue (ttm)
7.24B
Net Income Avi to Common (ttm)
851.5M
Diluted EPS (ttm)
7.55
Balance Sheet and Cash Flow
Total Cash (mrq)
5.66B
Total Debt/Equity (mrq)
19.13%
Levered Free Cash Flow (ttm)
886.93M